Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.34 USD | -1.02% | -3.28% | +18.44% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.44% | 699M | |
+7.25% | 113B | |
+11.00% | 106B | |
+1.02% | 22.27B | |
-12.23% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-5.97% | 17.24B | |
+7.39% | 14.29B | |
+34.90% | 12.52B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- Wedbush Lowers AnaptysBio's PT to $29 From $32, Removes Valuations for Rosnilimab in Rheumatoid Arthritis, ANB032 in Atopic Dermatitis; Keeps Neutral Rating